Text and Data Mining valid from 2019-03-11
Received: 29 June 2018
Accepted: 15 February 2019
First Online: 11 March 2019
: T.E. is an employee of AstraZeneca on leave of absence from the University of Cambridge, and an author on the study reporting the results from the lenvatinib plus everolimus clinical trial. The remaining authors declare no competing interests.